Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Bio-Thera Solutions)"
Count: 49
Selected: 0
| NCT ID | Title |
|---|
| NCT06139536 | Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients | ||
| NCT06123884 | BAT1308 Combined With Platinum-Based Chemotherapy± Bevacizumab For PDL1-Positive (CPS ≥1) Cervical Cancer | ||
| NCT06111196 | Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects | ||
| NCT06094179 | Evaluate the Safety, Tolerability of BAT6026 | ||
| NCT06044350 | A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders | ||
| NCT05968508 | A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects | ||
| NCT05879627 | To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors | ||
| NCT05865574 | A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection | ||
| NCT05848466 | Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients | ||
| NCT05803187 | Clinical Study of Stage IV Psoriasis in Children With Geleli | ||
| NCT05767060 | BAT7104 Injection in Patients With Advanced Malignant Tumors. | ||
| NCT05620017 | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection | ||
| NCT05576454 | Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects | ||
| NCT05518695 | Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects | ||
| NCT05439629 | Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration | ||
| NCT05414136 | Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 | ||
| NCT05405621 | Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009 | ||
| NCT05378737 | Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection | ||
| NCT05377944 | Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients | ||
| NCT05332730 | A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi® | ||
| NCT05200013 | BAT7104 in Patients With Advanced Solid Tumours | ||
| NCT05180526 | Assessment of Safety , Clinical Efficacy With QLETLI in Non-infectious Uveitis (UV) | ||
| NCT05155722 | Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors | ||
| NCT05148325 | Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors | ||
| NCT05141994 | Clinical Study on the Efficacy and Safety of BAT5906 Injection | ||
| NCT05120375 | Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China | ||
| NCT05116709 | Assessment of Safety and Preliminary Clinical Efficacy With BAT6005 in Advanced Malignant Solid Tumors | ||
| NCT05109650 | Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients | ||
| NCT05105971 | Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China | ||
| NCT05073484 | Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients | ||
| NCT05046431 | Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis | ||
| NCT04772105 | Clinical Study of the Safety and Efficacy of BAT5906 Injection | ||
| NCT04728360 | Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis | ||
| NCT04711343 | Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects | ||
| NCT04432766 | A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients | ||
| NCT04371185 | Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects | ||
| NCT04189211 | A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients | ||
| NCT04185649 | The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer | ||
| NCT04152759 | Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects | ||
| NCT04152148 | A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients | ||
| NCT04151329 | A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor | ||
| NCT04151212 | A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration | ||
| NCT04146285 | A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders | ||
| NCT04135508 | A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira | ||
| NCT03884517 | Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer | ||
| NCT03830203 | Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate | ||
| NCT03606876 | Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects | ||
| NCT03329911 | A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer | ||
| NCT03030430 | Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects |
